CA2404233A1 - Compositions and methods for the therapy and diagnosis of lung cancer - Google Patents

Compositions and methods for the therapy and diagnosis of lung cancer Download PDF

Info

Publication number
CA2404233A1
CA2404233A1 CA002404233A CA2404233A CA2404233A1 CA 2404233 A1 CA2404233 A1 CA 2404233A1 CA 002404233 A CA002404233 A CA 002404233A CA 2404233 A CA2404233 A CA 2404233A CA 2404233 A1 CA2404233 A1 CA 2404233A1
Authority
CA
Canada
Prior art keywords
seq
sequence
cdna sequence
polypeptide
determined cdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002404233A
Other languages
English (en)
French (fr)
Inventor
Steven G. Reed
Michael J. Lodes
Raodoh Mohamath
Heather Secrist
Darin R. Benson
Carol Yoseph Indirias
Robert A. Henderson
Steven P. Fling
Paul A. Algate
Mark Elliot
Jane Mannion
Michael D. Kalos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corporation
Steven G. Reed
Michael J. Lodes
Raodoh Mohamath
Heather Secrist
Darin R. Benson
Carol Yoseph Indirias
Robert A. Henderson
Steven P. Fling
Paul A. Algate
Mark Elliot
Jane Mannion
Michael D. Kalos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/738,973 external-priority patent/US20020110563A1/en
Application filed by Corixa Corporation, Steven G. Reed, Michael J. Lodes, Raodoh Mohamath, Heather Secrist, Darin R. Benson, Carol Yoseph Indirias, Robert A. Henderson, Steven P. Fling, Paul A. Algate, Mark Elliot, Jane Mannion, Michael D. Kalos filed Critical Corixa Corporation
Publication of CA2404233A1 publication Critical patent/CA2404233A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002404233A 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer Abandoned CA2404233A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US53803700A 2000-03-29 2000-03-29
US09/538,037 2000-03-29
US58893700A 2000-06-05 2000-06-05
US09/588,937 2000-06-05
US64087800A 2000-08-18 2000-08-18
US09/640,878 2000-08-18
US09/667,170 2000-09-20
US23451700P 2000-09-22 2000-09-22
US70451200A 2000-11-01 2000-11-01
US09/704,512 2000-11-01
US09/738,973 US20020110563A1 (en) 2000-11-01 2000-12-14 Compositions and methods for the therapy and diagnosis of lung cancer
US09/738,973 2000-12-14
PCT/US2001/009991 WO2001072295A2 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
CA2404233A1 true CA2404233A1 (en) 2001-10-04

Family

ID=27559252

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002404233A Abandoned CA2404233A1 (en) 2000-03-29 2001-03-28 Compositions and methods for the therapy and diagnosis of lung cancer

Country Status (7)

Country Link
JP (1) JP2004526401A (hu)
AU (1) AU2001261007A1 (hu)
CA (1) CA2404233A1 (hu)
CZ (1) CZ20023567A3 (hu)
HU (1) HUP0500345A2 (hu)
PL (1) PL366626A1 (hu)
WO (1) WO2001072295A2 (hu)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082212A1 (en) * 2000-07-20 2002-06-27 Millennium Pharmaceuticals, Inc. 7716, a novel human ATPase and uses therefor
WO2002092001A2 (en) * 2001-05-11 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
WO2004035789A1 (en) * 2002-10-18 2004-04-29 Lg Life Sciences Ltd. Gene families associated with cancers
DE10258051A1 (de) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge
WO2004055183A2 (en) * 2002-12-17 2004-07-01 Fondazione Centro San Raffaele Del Monte Tabor Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof
US20060241051A1 (en) 2002-12-26 2006-10-26 Chieko Kitada Metastin derivatives and use thereof
AR049938A1 (es) 2004-06-25 2006-09-13 Takeda Pharmaceutical Derivados de metastina y utilizacion de los mismos
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
AR058584A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos
JP2007263896A (ja) * 2006-03-29 2007-10-11 Univ Nagoya 肺癌患者の術後予後予測のための生物マーカー及びその方法
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
JP5648261B2 (ja) * 2006-12-20 2015-01-07 東レ株式会社 癌の検出方法
RU2498819C2 (ru) 2008-08-05 2013-11-20 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и профилактики злокачественных опухолей
ES2570731T3 (es) * 2008-08-05 2016-05-20 Toray Industries Método de detección de cáncer
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN104086625B (zh) 2008-10-22 2016-08-31 肿瘤疗法科学股份有限公司 Rab6kifl/kif20a表位肽及包含它的疫苗
US8828398B2 (en) 2010-02-04 2014-09-09 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
BR112012018951C8 (pt) 2010-02-04 2020-06-23 Toray Industries anticorpo monoclonal, composição farmacêutica, combinação farmacêutica, uso de um anticorpo, uso de uma composição farmacêutica e uso de uma combinação farmacêutica
DK2532367T3 (en) 2010-02-04 2018-11-19 Toray Industries PHARMACEUTICAL AGENT FOR TREATMENT AND / OR CANCER PREVENTION
DK2532680T3 (da) 2010-02-04 2015-07-20 Toray Industries Medicinsk sammensætning til behandling og/eller forebyggelse af cancer
RU2598258C2 (ru) 2010-02-04 2016-09-20 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики рака
MX340014B (es) 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
JP6065591B2 (ja) 2011-08-04 2017-01-25 東レ株式会社 癌の治療及び／又は予防用医薬組成物
KR101980557B1 (ko) 2011-08-04 2019-05-21 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
HUE047006T2 (hu) 2011-08-04 2020-04-28 Toray Industries Anti-caprin-1 antitesteket tartalmazó gyógyászati kompozíció rák kezelésére és/vagy megelõzésére
PL2740798T3 (pl) 2011-08-04 2017-07-31 Toray Industries, Inc. Kompozycja leku do leczenia i/lub zapobiegania nowotworom
PT2741085T (pt) 2011-08-04 2017-06-30 Toray Industries Método para a deteção de cancro prancreático
AU2012290955B2 (en) 2011-08-04 2017-04-27 Toray Industries, Inc. Drug composition for cancer treatment and/or prevention
PT2740489T (pt) 2011-08-04 2017-01-10 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção do cancro pancreático
DK2818481T3 (da) 2012-02-21 2019-10-14 Toray Industries Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
AU2013223161B2 (en) 2012-02-21 2017-10-19 Toray Industries, Inc. Medicinal composition for treating and/or preventing cancer
HUE045461T2 (hu) 2012-02-21 2019-12-30 Toray Industries Gyógyászati készítmény rák kezelésére
BR112014021101A2 (pt) 2012-02-21 2022-03-22 Toray Industries Anticorpo, composição farmacêutica, droga de combinação, dna e método de tratamento e/ou prevenção de câncer, uso de um anticorpo
RU2640245C2 (ru) 2012-03-30 2017-12-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или предотвращения рака печени
AU2013241043B2 (en) 2012-03-30 2017-11-09 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of gall bladder cancer
KR102056654B1 (ko) 2012-07-19 2019-12-17 도레이 카부시키가이샤 암의 검출 방법
BR112015001100A2 (pt) 2012-07-19 2018-03-27 Toray Industries, Inc. método de detecção de câncer
WO2015020212A1 (ja) 2013-08-09 2015-02-12 東レ株式会社 癌の治療及び／又は予防用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1187915A2 (en) * 1999-04-02 2002-03-20 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2001253594A1 (en) * 2000-04-17 2001-10-30 Pharmacia And Upjohn Company Novel g protein-coupled receptors
WO2001083553A2 (en) * 2000-05-03 2001-11-08 Pharmacia & Upjohn Company G protein-coupled receptors
WO2001096390A2 (en) * 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
PL366626A1 (en) 2005-02-07
CZ20023567A3 (cs) 2003-11-12
WO2001072295A2 (en) 2001-10-04
HUP0500345A2 (hu) 2005-07-28
JP2004526401A (ja) 2004-09-02
AU2001261007A1 (en) 2001-10-08
WO2001072295A3 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
CA2404233A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
CA2411278A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
US7749505B2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20030118599A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20060287513A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
EP1516049A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1446013A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001077168A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2002039885A2 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US20030069180A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
JP2004508812A (ja) 乳癌の治療および診断のための組成物および方法
EP1319069B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US6960570B2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1351967B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2001094409A2 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
US20060083749A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2002012331A2 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
US20040033230A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2003029468A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US20020110563A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20020156011A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
CA2537555A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1268797A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
ZA200209365B (en) Compositions and methods for the therapy and diagnosis of breast cancer.

Legal Events

Date Code Title Description
FZDE Discontinued